TuisZTS • SWX
add
Zoetis Inc
Markkapitalisasie
53,17Â mjd USD
P/V-verhouding
-
Dividend-opbrengs
-
PrimĂŞre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 2,39Â mjd | 3,02% |
Bedryfskoste | 848,00Â m | 1,07% |
Netto inkomste | 603,00Â m | 3,79% |
Netto winsgrens | 25,26 | 0,72% |
Wins per aandeel | 1,48 | 5,71% |
EBITDA | 903,00Â m | 8,27% |
Effektiewe belastingkoers | 20,76% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,31Â mjd | 16,36% |
Totale bates | 15,47Â mjd | 8,64% |
Totale aanspreeklikheid | 12,14Â mjd | 28,19% |
Totale ekwiteit | 3,33 mjd | — |
Uitstaande aandele | 422,13 m | — |
Prys om te bespreek | — | — |
Opbrengs op bates | 13,52% | — |
Opbrengs op kapitaal | 16,34% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 603,00Â m | 3,79% |
Kontant van bedrywe | 893,00Â m | -1,33% |
Kontant van beleggings | -166,00Â m | -231,75% |
Kontant van finansiering | -495,00Â m | 33,56% |
Netto kontantverandering | 228,00Â m | -16,48% |
Beskikbare kontantvloei | 881,88Â m | -29,65% |
Meer oor
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Gestig
1952
Webwerf
Werknemers
14Â 500